Danaher Co. (NYSE:DHR) Shares Sold by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio reduced its position in Danaher Co. (NYSE:DHR - Free Report) by 3.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 290,924 shares of the conglomerate's stock after selling 9,510 shares during the quarter. Public Employees Retirement System of Ohio's holdings in Danaher were worth $80,883,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of DHR. Fort Pitt Capital Group LLC lifted its stake in shares of Danaher by 3.2% during the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate's stock worth $66,194,000 after buying an additional 7,421 shares during the period. Good Life Advisors LLC acquired a new stake in shares of Danaher during the third quarter worth $217,000. Oak Thistle LLC acquired a new stake in shares of Danaher during the second quarter worth $363,000. Harvest Portfolios Group Inc. lifted its position in Danaher by 1.2% during the third quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate's stock valued at $56,233,000 after purchasing an additional 2,465 shares during the period. Finally, Diversified Trust Co lifted its position in Danaher by 75.4% during the second quarter. Diversified Trust Co now owns 4,360 shares of the conglomerate's stock valued at $1,090,000 after purchasing an additional 1,874 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Price Performance

NYSE DHR traded up $6.07 during trading hours on Monday, hitting $236.19. 1,702,697 shares of the company's stock traded hands, compared to its average volume of 2,774,418. Danaher Co. has a 52-week low of $217.96 and a 52-week high of $281.70. The company has a market capitalization of $170.60 billion, a PE ratio of 43.92, a PEG ratio of 4.23 and a beta of 0.83. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The firm's 50-day moving average is $250.76 and its 200-day moving average is $258.32.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business had revenue of $5.80 billion during the quarter, compared to analysts' expectations of $5.59 billion. During the same quarter in the prior year, the company posted $2.02 EPS. The business's revenue for the quarter was up 3.1% on a year-over-year basis. Equities analysts forecast that Danaher Co. will post 7.5 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were paid a $0.27 dividend. The ex-dividend date was Friday, September 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.46%. Danaher's dividend payout ratio (DPR) is 20.61%.

Analyst Ratings Changes

A number of research firms recently issued reports on DHR. UBS Group decreased their target price on shares of Danaher from $309.00 to $305.00 and set a "buy" rating for the company in a research report on Wednesday, October 23rd. KeyCorp boosted their target price on shares of Danaher from $290.00 to $310.00 and gave the company an "overweight" rating in a research report on Wednesday, October 23rd. Robert W. Baird decreased their target price on shares of Danaher from $278.00 to $277.00 and set an "outperform" rating for the company in a research report on Wednesday, October 23rd. TD Cowen upped their price objective on shares of Danaher from $310.00 to $315.00 and gave the stock a "buy" rating in a research report on Wednesday, October 23rd. Finally, Wells Fargo & Company assumed coverage on shares of Danaher in a research report on Tuesday, August 27th. They issued an "equal weight" rating and a $280.00 price objective for the company. Six analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat, Danaher currently has an average rating of "Moderate Buy" and an average target price of $287.16.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.